TY - JOUR T1 - Erythropoietin and blood doping JF - British Journal of Sports Medicine JO - Br J Sports Med SP - i30 LP - i34 DO - 10.1136/bjsm.2006.027532 VL - 40 IS - suppl 1 AU - N Robinson AU - S Giraud AU - C Saudan AU - N Baume AU - L Avois AU - P Mangin AU - M Saugy Y1 - 2006/07/01 UR - http://bjsm.bmj.com/content/40/suppl_1/i30.abstract N2 - Objective and method: To outline the direct and indirect approaches in the fight against blood doping in sports, the different strategies that have been used and are currently being used to fight efficiently against blood doping are presented and discussed. Results and conclusions: The paper outlines the different approaches and diagnostic tools that some federations have to identify and target sportspeople demonstrating abnormal blood profiles. Originally blood tests were introduced for medical reasons and for limiting misuse of recombinant human erythropoietin (rHuEPO). In this way it became possible to prevent athletes with haematocrit levels well above normal, and potentially dangerous for their health, competing in sport. Today, with nearly a decade of blood testing experience, sports authorities should be familiar with some of the limitations and specially the ability of blood tests performed prior to competitions to fight efficiently against the misuse of rHuEPO, blood transfusion, and artificial haemoglobin. ER -